GNMX
Aevi Genomic Medicine, Inc.
GNMX
GNMX
Delisted
GNMX was delisted on the 3rd of February, 2020.
28 hedge funds and large institutions have $6.12M invested in Aevi Genomic Medicine, Inc. in 2019 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 2 closing their positions.
Holders
28
Holders Change
+3
Holders Change %
+12%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
8
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$156K |
2 |
2
Citadel Advisors
Miami,
Florida
|
$0 |
3 |
BC
3
Birchview Capital
Burlington,
Vermont
|
$0 |